Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

UK's Croda cuts 2023 profit forecast on weak demand

Published 09/10/2023, 07:19
Updated 09/10/2023, 08:50
© Reuters.

(Reuters) -Croda, which supplies ingredients to global cosmetic majors such as Estee Lauder (NYSE:EL), cut its annual profit outlook on Monday, hurt by destocking and weak demand, mainly in key beauty care business in North America.

Shares in the FTSE 100-listed UK speciality chemical group slid as much as 11.5% to 4,242 pence - their lowest since April 2020 - in early trading.

Retailers selling beauty products globally have been battling weak demand for much of the year, amid a slow recovery at duty-free and travel destinations and especially in the key China market.

At the same time, consumers have been spending less on non-essential items due to high inflation, while companies struggle to protect profit margins as costs surge.

"Customers have continued to reduce their ingredient inventories in consumer care, crop and industrial end markets, due to a combination of destocking and a weaker demand environment," Croda, which also counts Unilever (LON:ULVR) and Procter & Gamble among its customers, said in a statement.

The company now expects 2023 group adjusted profit before tax of 300 million pounds to 320 million pounds ($366-$391 million), compared with company-compiled analysts' average estimate of 369.6 million pounds. It had previously expected 370 million-400 million pounds.

Croda's consumer division, its biggest, serves the beauty, fragrance and home care markets, and makes up half its annual revenues.

Third-quarter sales volume in its beauty care business was lower than expected in July and August, with the North American market not recovering from weakness in the previous quarter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Croda, headquartered in Yorkshire, said it had implemented several cost-cutting measures since June, including optimising production through plant shutdowns and reduced shift patterns.

It has been shifting focus to its life sciences and consumer divisions, after completing the sale of most of its performance technologies and industrial chemicals division to commodities group Cargill Inc last year.

Shares of its rival Synthomer (LON:SYNTS) were down 1.3%, and the broader FTSE 100 dipped 0.1%.

($1 = 0.8193 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.